Team Leader in Cancer Immunotherapy

28/10/2018, 23:55

Strategic Initiatives
Strategic Initiatives
Full time
Fixed Term
6 years
Starting salary £62,157 per annum
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

We are committed to take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.  To facilitate this we are building a state-of-the-art Centre for Cancer Drug Discovery so we can discover even more innovative cancer drugs; we are building capacity in cancer immunology and immunotherapy and we are integrating the ICR’s drug discovery teams with research on cancer evolution and immunology, so that researchers can collaborate to combat cancer’s ability to adapt, evolve and evade the immune system. 

With funding from the CRIS Cancer Foundation ICR is looking for an enthusiastic and motivated team leader to establish an independent research programme focusing on immunotherapy to help us build a critical mass of immune-oncologists.  This new team will be expected to work in association with Professor Mel Greaves FRS, Professor Raj Chopra and Professor Alan Melcher. 

Informal enquiries are welcomed, and should be addressed to Professor Mel Greaves (email: or Professor Raj Chopra (

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff. We particularly welcome applications from women and people from ethnic minorities, as they are under-represented at the ICR at this level.
Additional Documentation for Candidates

This Program is closed to applications.